Published in Stroke on March 22, 2007
Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology (2010) 2.32
Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A (2009) 1.76
Molecular ultrasound imaging: current status and future directions. Clin Radiol (2010) 1.51
Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol (2009) 1.08
Molecular imaging of disease with targeted contrast ultrasound imaging. Transl Res (2012) 1.02
Molecular imaging of thrombus: technology in evolution. Circulation (2012) 0.86
An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions. Invest Radiol (2010) 0.83
Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies. Ultrasound Med Biol (2012) 0.82
Contrast-enhanced ultrasound (CEUS) in nephrology: Has the time come for its widespread use? Clin Exp Nephrol (2014) 0.82
Ultrasound imaging for risk assessment in atherosclerosis. Int J Mol Sci (2015) 0.79
Effects of ultrasound and ultrasound contrast agent on vascular tissue. Cardiovasc Ultrasound (2012) 0.78
Cardiovascular molecular imaging with contrast ultrasound: principles and applications. Korean Circ J (2014) 0.77
A Targeting Microbubble for Ultrasound Molecular Imaging. PLoS One (2015) 0.77
Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets. Theranostics (2015) 0.77
Deep vein thrombosis: current status and nanotechnology advances. Biotechnol Adv (2012) 0.77
The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology. World J Urol (2011) 0.77
Emerging diagnostic and therapeutic molecular imaging applications in vascular disease. Vasc Med (2011) 0.76
Design of Albumin-Coated Microbubbles Loaded With Polylactide Nanoparticles. J Ultrasound Med (2015) 0.75
Molecular mechanisms of the effect of ultrasound on the fibrinolysis of clots. J Thromb Haemost (2015) 0.75
ROLE OF TRANSCRANIAL COLOUR-CODED DUPLEX SONOGRAPHY IN STROKE MANAGEMENT - REVIEW ARTICLE. West Afr J Ultrasound (2016) 0.75
Advanced imaging in acute and chronic deep vein thrombosis. Cardiovasc Diagn Ther (2016) 0.75
Ultrasound molecular imaging of vascular endothelial growth factor receptor 2 expression for endometrial receptivity evaluation. Theranostics (2015) 0.75
The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res (2003) 52.80
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
UniProtKB/Swiss-Prot. Methods Mol Biol (2007) 7.05
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol (2008) 3.91
Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke (2007) 2.56
Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2009) 2.51
European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis (2003) 2.35
Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology (2010) 2.32
Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis (2008) 2.26
State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B (2002) 2.19
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol (2010) 2.12
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology. Neuroepidemiology (2005) 1.92
Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res (2004) 1.91
Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci (2005) 1.77
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain (2005) 1.73
Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US. Radiology (2011) 1.64
BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol (2010) 1.62
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke (2012) 1.52
Characterization of carotid artery plaques using real-time compound B-mode ultrasound. Stroke (2004) 1.46
Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J Biol Chem (2005) 1.40
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis (2011) 1.40
Simulation of intracranial acoustic fields in clinical trials of sonothrombolysis. Ultrasound Med Biol (2009) 1.34
A concerted appeal for international cooperation in preclinical stroke research. Stroke (2013) 1.32
Characteristics of SonoVuetrade mark. Echocardiography (1999) 1.32
Current methods for attaching targeting ligands to liposomes and nanoparticles. J Pharm Sci (2004) 1.26
Hippocampal lesion patterns in acute posterior cerebral artery stroke: clinical and MRI findings. Stroke (2009) 1.23
Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech (2005) 1.22
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm (2002) 1.21
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis (2006) 1.20
Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug Chem (2007) 1.18
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry (2007) 1.17
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm (2005) 1.17
Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol (2010) 1.17
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm (2003) 1.13
Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study. Stroke (2012) 1.13
Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke (2009) 1.12
High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids (2004) 1.11
Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol (2011) 1.11
Assessment of intracranial collateral flow by using dynamic arterial spin labeling MRA and transcranial color-coded duplex ultrasound. Stroke (2008) 1.09
Early spontaneous recanalization following acute carotid occlusion. J Neuroimaging (2008) 1.06
The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol (2012) 1.04
MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc Dis (2009) 1.04
Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjug Chem (2006) 1.04
Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology (2012) 1.03
Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc (2006) 1.01
GeneFarm, structural and functional annotation of Arabidopsis gene and protein families by a network of experts. Nucleic Acids Res (2005) 1.01
Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci (2003) 1.00
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study. J Am Geriatr Soc (2008) 1.00
Ultrasound microbubble destruction imaging in acute middle cerebral artery stroke. Stroke (2004) 1.00
A mobile olfactometer for fMRI-studies. J Neurosci Methods (2012) 0.97
Gadofluorine m uptake in stem cells as a new magnetic resonance imaging tracking method: an in vitro and in vivo study. Invest Radiol (2006) 0.96
Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species. Invest Radiol (2012) 0.95
Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening. Mol Ther Nucleic Acids (2013) 0.95
Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. J Control Release (2011) 0.95
Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded microbubbles. Mol Pharm (2011) 0.94
Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study. J Neurol (2012) 0.94
Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting. Health Policy (2006) 0.93
Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol (2003) 0.92
Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes. Cerebrovasc Dis (2008) 0.92
Ultrasound in the treatment of ischaemic stroke. Lancet Neurol (2003) 0.92
Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data. Neuroepidemiology (2006) 0.92
Increased medial orbitofrontal and amygdala activation: evidence for a systems-level endophenotype of bipolar I disorder. Am J Psychiatry (2012) 0.91
Statins and stroke prevention. Cerebrovasc Dis (2007) 0.91
Influence of neuroendocrine tumor cells on proliferation in prostatic carcinoma. Hum Pathol (2005) 0.91
Protein S-100B--a prognostic marker for cerebral damage. Curr Med Chem (2006) 0.90
Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent. Ultrasound Med Biol (2012) 0.89
Lipoaspirate-derived adult mesenchymal stem cells improve functional outcome during intracerebral hemorrhage by proliferation of endogenous progenitor cells stem cells in intracerebral hemorrhages. Neurosci Lett (2008) 0.89
Genome and transcriptome sequencing identifies breeding targets in the orphan crop tef (Eragrostis tef). BMC Genomics (2014) 0.89
Parametric imaging for characterizing focal liver lesions in contrast-enhanced ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control (2010) 0.88
Reorganization of gap junctions after focused ultrasound blood-brain barrier opening in the rat brain. J Cereb Blood Flow Metab (2010) 0.88
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting. Eur J Pharm Biopharm (2004) 0.88
Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Radiology (2003) 0.87
Clearance of albumin following ultrasound-induced blood-brain barrier opening is mediated by glial but not neuronal cells. Brain Res (2011) 0.87
Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data. Stroke (2011) 0.87
In vitro sonothrombolysis of human blood clots with BR38 microbubbles. Ultrasound Med Biol (2012) 0.87
Clinical and MRI patterns of pericallosal artery infarctions: the significance of supplementary motor area lesions. J Neurol (2011) 0.87
A polydioxanone electrospun valved patch to replace the right ventricular outflow tract in a growing lamb model. Biomaterials (2010) 0.86